Literature DB >> 29268835

Predictive Validity of the Brazilian Portuguese Version of the Family Questionnaire for Relapse in Patients With Schizophrenia.

Ana Carolina G Zanetti, Marcia A Ciol, Georg Wiedemann, João Mazzoncini de Azevedo-Marques, Rosana Aparecida Spadoti Dantas, Edilaine Cristina da Silva Gherardi-Donato, Kelly Graziani Giacchero Vedana, Sueli Aparecida Frari Galera.   

Abstract

BACKGROUND AND
PURPOSE: The Family Questionnaire-Brazilian Portuguese Version (FQ-BPV) has been preliminarily validated in the Brazilian population. This study assessed the predictive validity of the FQ-BPV for relapse in patients with schizophrenia.
METHODS: Ninety-four dyads (patients with schizophrenia and their relatives) were recruited from three mental health clinics. Expressed emotion was assessed using the FQ-BPV. Presence of relapse was assessed at 6-, 9-, 12-, and 18-month follow-ups and analyzed through logistic regressions.
RESULTS: The critical comments (CC) domain of the FQ-BPV was statistically significant at 18 months. However, the model was not sufficiently robust to classify individuals correctly into relapse or no relapse categories.
CONCLUSION: The FQ-BPV did not predict relapse well and we cannot recommend it for that purpose in Brazil without further studies.

Entities:  

Mesh:

Year:  2017        PMID: 29268835     DOI: 10.1891/1061-3749.25.3.559

Source DB:  PubMed          Journal:  J Nurs Meas        ISSN: 1061-3749


  2 in total

1.  Caregivers' burden and schizophrenia patients' quality of life: Sequential mediating effects of expressed emotion and perceived expressed emotion.

Authors:  Yicheng Wei; Yanan Peng; Yan Li; Lanjun Song; Kang Ju; Juzhe Xi
Journal:  Front Psychiatry       Date:  2022-08-25       Impact factor: 5.435

2.  Relatives' attachment anxiety mediates the association between perceived loss and expressed emotion in early psychosis.

Authors:  Lídia Hinojosa-Marqués; Tecelli Domínguez-Martínez; Tamara Sheinbaum; Paula Cristóbal-Narváez; Thomas R Kwapil; Neus Barrantes-Vidal
Journal:  PLoS One       Date:  2019-10-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.